Page last updated: 2024-11-01

ondansetron and Respiration Disorders

ondansetron has been researched along with Respiration Disorders in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cortés-Flores, AO1
Jiménez-Tornero, J1
Morgan-Villela, G1
Delgado-Gómez, M1
Zuloaga-Fernández Del Valle, CJ1
García-Rentería, J1
Rendón-Félix, J1
Fuentes-Orozco, C1
Macías-Amezcua, MD1
Ambriz-González, G1
Alvarez-Villaseñor, AS1
Urias-Valdez, D1
Chavez-Tostado, M1
Contreras-Hernández, GI1
González-Ojeda, A1

Trials

1 trial available for ondansetron and Respiration Disorders

ArticleYear
Effects of preoperative dexamethasone on postoperative pain, nausea, vomiting and respiratory function in women undergoing conservative breast surgery for cancer: Results of a controlled clinical trial.
    European journal of cancer care, 2018, Volume: 27, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Analgesics, Opioid; Antiemetics; Breast Neoplasms; Dexamethasone; Doubl

2018